Patents by Inventor Troy Messick

Troy Messick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF EPSTEIN-BARR NUCLEAR ANTIGEN 1
    Publication number: 20160168144
    Abstract: The present invention embraces compounds that modulate the activity of Epstein-Barr Nuclear Antigen 1 (EBNA1) protein and use thereof in methods for treating latent Epstein-Barr virus infection.
    Type: Application
    Filed: February 26, 2016
    Publication date: June 16, 2016
    Applicant: The Wistar Institute
    Inventors: Paul M. Lieberman, Troy Messick
  • Compositions and methods for modulating the activity of Epstein-Barr nuclear antigen 1
    Patent number: 9309212
    Abstract: The present invention embraces compounds that modulate the activity of Epstein-Barr Nuclear Antigen 1 (BBNA1) protein and use thereof in methods for treating latent Epstein-Barr virus infection. R7 is a substituted or unsubstituted phenyl, pyridyl, or pyrimidinyl group. A pharmaceutical composition comprising a compound of the invention in admixture with a pharmaceutically acceptable carrier is also provide as are methods for modulating the activity of Epstein-Barr Nuclear Antigen 1 (EBNA1) protein and treating a latent EpsteinBarr virus infection with a composition of the present invention.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: April 12, 2016
    Assignee: The Wistar Institute
    Inventors: Paul M. Lieberman, Troy Messick
  • COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF EPSTEIN-BARR NUCLEAR ANTIGEN 1
    Publication number: 20140113897
    Abstract: The present invention embraces compounds that modulate the activity of Epstein-Barr Nuclear Antigen 1 (BBNA1) protein and use thereof in methods for treating latent Epstein-Barr virus infection. R7 is a substituted or unsubstituted phenyl, pyridyl, or pyrimidinyl group. A pharmaceutical composition comprising a compound of the invention in admixture with a pharmaceutically acceptable carrier is also provide as are methods for modulating the activity of Epstein-Barr Nuclear Antigen 1 (EBNA1) protein and treating a latent EpsteinBarr virus infection with a composition of the present invention.
    Type: Application
    Filed: May 22, 2012
    Publication date: April 24, 2014
    Applicant: THE WISTAR INSTITUTE
    Inventors: Paul M. Lieberman, Troy Messick
  • Histogram-based enrichment delay
    Patent number: 6578557
    Abstract: A method for regulation of an engine of a vehicle by manner of temperature control delays based on a target temperature of a component of the engine. Once enrichment has been triggered, enrichment is continued to ensure a temperature of the component is below its target for a specified time, thereby ensuring that the temperature of the component has not exceeded its target temperature for more than a certain percentage of its life.
    Type: Grant
    Filed: December 5, 2002
    Date of Patent: June 17, 2003
    Assignee: DaimlerChrysler Corporation
    Inventor: Troy A. Messick